Alison O’Mahony

2.1k citations

19 papers · 1.2k indexed · h-index 11

Hematology top 5%
- Acute Myeloid Leukemia Research 2
Immunology top 5%
- Immunodeficiency and Autoimmune Disorders 2
- Biosimilars and Bioanalytical Methods 2
Genetics top 5%
- Chronic Lymphocytic Leukemia Research 2
Cancer Research top 10%
Molecular Biology
- Protein Degradation and Inhibitors 3
Radiology, Nuclear Medicine and Imaging
- Monoclonal and Polyclonal Antibodies Research 5
Oncology
- Cytokine Signaling Pathways and Interactions 3
Cellular and Molecular Neuroscience
- Neuroscience and Neuropharmacology Research 2

Co-authors: Warner C. Greene Romas Geleziunas Xin Lin Yajun Mu Stefan Knapp Susanne Müller O. Fedorov Christopher Wells
Cited by: Hematology Immunology Genetics
Journals: Proceedings of the National Academy of Sciences (2 papers)The Journal of Immunology (1 paper)PLoS ONE (1 paper)
Partner nations: United States United Kingdom Switzerland

In The Last Decade

Alison O’Mahony

18 papers receiving 1.2k citations

Peers

Countries citing papers authored by Alison O’Mahony

Since Specialization

Citations

This map shows the geographic impact of Alison O’Mahony's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison O’Mahony with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison O’Mahony more than expected).

Fields of papers citing papers by Alison O’Mahony

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison O’Mahony. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison O’Mahony. The network helps show where Alison O’Mahony may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Alison O’Mahony, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Alison O’Mahony Line = papers co-authored together Alison O’Mahony links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work
1	The First CRISPR-Based Therapeutic (SL_1.52) for African Swine Fever Is Effective in Swine Viruses ·Naveen Verma,Alison O’Mahony,Rahema Mohammad,Dylan Keiser,Craig W. Mosman,Davidw . Holden,Karin M. Starr,Johann Bauer,B. K. Bauer,Roypim Suntisukwattana,Waranya Atthaapa,Angkana Tantituvanont,Dachrit Nilubol,Douglas P. Gladue	2025	0
2	A tubulin binding molecule drives differentiation of acute myeloid leukemia cells iScience ·Thomas R. Jackson,Aini Vuorinen,Laia Josa‐Culleré,Katrina S. Madden,Daniel Conole,Thomas J. Cogswell,Isabel V. L. Wilkinson,Laura M. Kettyle,Douzi Zhang,Alison O’Mahony,Deanne Gracias,Lorna McCall,Robert Westwood,Georg C. Terstappen,Stephen G. Davies,Edward W. Tate,Graham M. Wynne,Paresh Vyas,Angela J. Russell,Thomas A. Milne	2022	4
3	Efficacy and Pharmacodynamic Modeling of the BTK Inhibitor Evobrutinib in Autoimmune Disease Models The Journal of Immunology ·Philipp Haselmayer,Montserrat Camps,Lesley Liu‐Bujalski,Ngan Nguyen,Federica Morandi,Jared Head,Alison O’Mahony,Simone C. Zimmerli,Lisa Bruns,Andrew T. Bender,Patricia Schroeder,Roland Grenningloh	2019	108
4	Discriminating phenotypic signatures identified for tocilizumab, adalimumab, and tofacitinib monotherapy and their combinations with methotrexate Journal of Translational Medicine ·Alison O’Mahony,Markus R. John,Hanna Cho,Misato Hashizume,Ernest Choy	2018	6
5	AB0050 Biomap® phenotypic profiling of two batches of originator etanercept reveals equivalent activity signatures consistent with conserved biological activity Annals of the Rheumatic Diseases ·Alison O’Mahony,Ellen L. Berg,Heather Jones,Brian Fitzpatrick,Brian Hassett,Steven Vicik,Lisa Marshall,K. Roshak,E. Choy	2018	1
6	Targeting JAK2 reduces GVHD and xenograft rejection through regulation of T cell differentiation Proceedings of the National Academy of Sciences ·Brian C. Betts,David Bastian,Supinya Iamsawat,Hung Nguyen,Jessica Heinrichs,Yongxia Wu,Anusara Daenthanasanmak,Anandharaman Veerapathran,Alison O’Mahony,Kelly Walton,Jordan Reff,Pedro Horna,Elizabeth M. Sagatys,Marie Catherine Lee,Jack W. Singer,Ying‐Jun Chang,Chen Liu,Joseph Pidala,Claudio Anasetti,Xue‐Zhong Yu	2018	53
7	Mechanisms of Skin Toxicity Associated with Metabotropic Glutamate Receptor 5 Negative Allosteric Modulators Cell chemical biology ·Falgun Shah,Antonia F. Stepan,Alison O’Mahony,Sharlene Velichko,Alexandra E. Folias,Christopher Houle,Christopher L. Shaffer,John Marcek,Jessica Whritenour,Robert V. Stanton,Ellen L. Berg	2017	26
8	THU0180 Systems based investigation of the anti-immunogenic potential of dmards for rheumatoid arthritis using human primary cell-based biomap® phenotypic profiling Annals of the Rheumatic Diseases ·Alison O’Mahony,Ernest Choy	2017	1
9	CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses Proceedings of the National Academy of Sciences ·Ariane Hammitzsch,C. Tallant,O. Fedorov,Alison O’Mahony,Paul E. Brennan,Duncan A. Hay,Fernando O. Martínez,Hussein Al‐Mossawi,Jelle de Wit,Matteo Vecellio,Christopher Wells,B P Wordsworth,Susanne Müller,Stefan Knapp,Paul Bowness	2015	195
10	Elucidating Mechanisms of Toxicity Using Phenotypic Data from Primary Human Cell Systems—A Chemical Biology Approach for Thrombosis-Related Side Effects International Journal of Molecular Sciences ·Ellen L. Berg,Mark A. Polokoff,Alison O’Mahony,Dat Nguyen,Xitong Li	2015	20
11	Dual kinase-bromodomain inhibitors for rationally designed polypharmacology Nature Chemical Biology ·Pietro Ciceri,Susanne Müller,Alison O’Mahony,O. Fedorov,P. Filippakopoulos,Jeremy P. Hunt,Elisabeth A. Lasater,Gabriel Pallares,S. Picaud,Christopher Wells,Sarah Martin,Lisa Wodicka,Neil P. Shah,Daniel K. Treiber,Stefan Knapp	2014	261
12	THU0526 Tocilizumab is Less Dependent than Adalimumab on Supplementary Effects of Methotrexate for Immunoregulation: A Biomap® Profiling Study Annals of the Rheumatic Diseases ·Alison O’Mahony,Elke Berg,Markus R. John,Kandeepan Ganeshalingam,E.H. Choy	2014	4
13	Regulation of IL-17A Production Is Distinct from IL-17F in a Primary Human Cell Co-culture Model of T Cell-Mediated B Cell Activation PLoS ONE ·Andrew C. Melton,Jennifer Melrose,Liisa Alajoki,Sylvie Privat,Hanna Cho,Naomi Brown,Ana Marija Plavec,Dat Nguyen,Elijah D. Johnston,Jian Yang,Mark A. Polokoff,Ivan Plavec,Ellen L. Berg,Alison O’Mahony	2013	39
14	RN486, a Selective Bruton's Tyrosine Kinase Inhibitor, Abrogates Immune Hypersensitivity Responses and Arthritis in Rodents Journal of Pharmacology and Experimental Therapeutics ·Daigen Xu,Yong Kim,Jennifer Postelnek,Minh Diem Vu,Dong‐Qing Hu,Cheng Liao,Mike Bradshaw,Jonathan C. Hsu,Jun Zhang,Achal Pashine,Dinesh Srinivasan,John Woods,Anita Levin,Alison O’Mahony,Timothy D. Owens,Yan Lou,Ronald J. Hill,Satwant K. Narula,Julie A. DeMartino,Jay S. Fine	2012	105
15	NF-κB/Rel Regulates Inhibitory and Excitatory Neuronal Function and Synaptic Plasticity Molecular and Cellular Biology ·Alison O’Mahony,Jacob Raber,Mauricio Montaño,Erik D. Foehr,Victor Z. Han,Shao-ming Lu,Hakju Kwon,Anthony LeFevour,Shikha Chakraborty‐Sett,Warner C. Greene	2006	92
16	Differentiation-dependent mechanisms of transcriptional regulation of the catalytic subunit of phosphorylase kinase Biochemical Journal ·Alison O’Mahony,Donal A. Walsh	2002	1
17	Differentiation-dependent mechanisms of transcriptional regulation of the catalytic subunit of phosphorylase kinase Biochemical Journal ·Alison O’Mahony,Donal A. Walsh	2002	1
18	Activation of the Heterodimeric IκB Kinase α (IKKα)-IKKβ Complex Is Directional: IKKα Regulates IKKβ under Both Basal and Stimulated Conditions Molecular and Cellular Biology ·Alison O’Mahony,Xin Lin,Romas Geleziunas,Warner C. Greene	2000	103
19	Protein Kinase C-θ Participates in NF-κB Activation Induced by CD3-CD28 Costimulation through Selective Activation of IκB Kinase β Molecular and Cellular Biology ·Xin Lin,Alison O’Mahony,Yajun Mu,Romas Geleziunas,Warner C. Greene	2000	228

About Alison O’Mahony

Alison O’Mahony is a scholar working on Immunology, Hematology and Genetics, having authored 19 papers that have together received 1.2k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (5 papers), Protein Degradation and Inhibitors (3 papers), Cytokine Signaling Pathways and Interactions (3 papers), Acute Myeloid Leukemia Research (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), Neuroscience and Neuropharmacology Research (2 papers), Immunodeficiency and Autoimmune Disorders (2 papers) and Biosimilars and Bioanalytical Methods (2 papers). The work is most often cited by research in Hematology (256 citations), Immunology (462 citations) and Genetics (193 citations). Alison O’Mahony has collaborated with scholars based in United States, United Kingdom and Switzerland. Frequent co-authors include Warner C. Greene, Romas Geleziunas, Xin Lin, Yajun Mu, Stefan Knapp, Susanne Müller, O. Fedorov, Christopher Wells, P. Filippakopoulos and Lisa Wodicka. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact